Literature DB >> 17991118

Pap smear screening history of women with squamous cell carcinoma and adenocarcinoma of the cervix.

Sok Cheon Pak1, Martje Martens, Ruud Bekkers, Alex J Crandon, Russell Land, James L Nicklin, Lewis C Perrin, Andreas Obermair.   

Abstract

BACKGROUND: Since the introduction of the Pap smear screening, the incidence of squamous cell carcinoma (SCC) has decreased significantly, but the incidence of adenocarcinoma (AC) relative to SCC has increased. AIM: To compare the Pap smear history of patients with AC and SCC of the cervix.
METHODS: Patients for the study were identified from the database of Queensland Centre for Gynaecological Cancer. Patients with AC and SCC were matched for age at diagnosis and International Federation of Gynecology and Obstetrics stage. The final population included 188 matched pairs, being 376 patients in total. Data were collected upon the histological type of cancer, result of the most recent Pap smear, date and result of the Pap smear prior to the most recent Pap smear and symptoms. Chi-squared tests and Fisher's exact test were used to compare the two patient groups for several variables.
RESULTS: Patients with AC had significantly more false-negative results on their most recent Pap smear (P<0.0001) than patients with SCC. The incidence of symptoms such as bleeding and/or vaginal discharge was comparable in patients with AC and SCC. The time between the most recent Pap smear and the diagnosis of cervical cancer was significantly shorter for patients with AC (P=0.01).
CONCLUSIONS: Patients with AC had Pap smears more regularly than those with SCC, and their most recent Pap smear was significantly more likely to be normal. Thus, Pap smear prior to a diagnosis of AC is more likely than SCC false-negative and therefore not indicative of cervical cancer.

Entities:  

Mesh:

Year:  2007        PMID: 17991118     DOI: 10.1111/j.1479-828X.2007.00788.x

Source DB:  PubMed          Journal:  Aust N Z J Obstet Gynaecol        ISSN: 0004-8666            Impact factor:   2.100


  8 in total

1.  Characteristics of 44 cervical cancers diagnosed following Pap-negative, high risk HPV-positive screening in routine clinical practice.

Authors:  Walter Kinney; Barbara Fetterman; J Thomas Cox; Thomas Lorey; Tracy Flanagan; Philip E Castle
Journal:  Gynecol Oncol       Date:  2011-01-26       Impact factor: 5.482

2.  Evidence for the need of educational programs for cervical screening in rural Tanzania.

Authors:  Lisa M Peters; Amr S Soliman; Pendo Bukori; Jesca Mkuchu; Twalib Ngoma
Journal:  J Cancer Educ       Date:  2010-06       Impact factor: 2.037

3.  Quantitative DNA methylation analysis of paired box gene 1 and LIM homeobox transcription factor 1 α genes in cervical cancer.

Authors:  Ling Xu; Jun Xu; Zheng Hu; Baohua Yang; Lifeng Wang; Xiao Lin; Ziyin Xia; Zhiling Zhang; Yunheng Zhu
Journal:  Oncol Lett       Date:  2018-01-26       Impact factor: 2.967

4.  Methylation analysis of SFRP genes family in cervical adenocarcinoma.

Authors:  Ya-Wen Lin; Ming-Tzeung Chung; Hung-Cheng Lai; Ming De Yan; Yu-Leung Shih; Cheng-Chang Chang; Mu-Hsien Yu
Journal:  J Cancer Res Clin Oncol       Date:  2009-06-10       Impact factor: 4.553

5.  PAX1/SOX1 DNA methylation and cervical neoplasia detection: a Taiwanese Gynecologic Oncology Group (TGOG) study.

Authors:  Hung-Cheng Lai; Yu-Che Ou; Tze-Chien Chen; Huei-Jean Huang; Ya-Min Cheng; Chi-Hau Chen; Tang-Yuan Chu; Shih-Tien Hsu; Cheng-Bin Liu; Yao-Ching Hung; Kuo-Chang Wen; Mu-Hsien Yu; Kung-Liahng Wang
Journal:  Cancer Med       Date:  2014-05-03       Impact factor: 4.452

6.  Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix?

Authors:  Alejandra Castanon; Rebecca Landy; Peter D Sasieni
Journal:  Int J Cancer       Date:  2016-05-06       Impact factor: 7.396

7.  Cytologic patterns of cervical adenocarcinomas with emphasis on factors associated with underdiagnosis.

Authors:  Rachel D Conrad; Angela H Liu; Nicolas Wentzensen; Roy R Zhang; S Terence Dunn; Sophia S Wang; Mark Schiffman; Michael A Gold; Joan L Walker; Rosemary E Zuna
Journal:  Cancer Cytopathol       Date:  2018-10-23       Impact factor: 5.284

8.  Prior cervical cytology and high-risk HPV testing results for 311 patients with invasive cervical adenocarcinoma: a multicenter retrospective study from China's largest independent operator of pathology laboratories.

Authors:  Fengxiang Xie; Liran Zhang; Dongman Zhao; Xuefen Wu; Mingsong Wei; Xuelian Zhang; Xiaohui Wu; Hao Fang; Xue Xu; Meng Yang; Debo Qi
Journal:  BMC Infect Dis       Date:  2019-11-11       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.